Synchron

About

Synchron is a neurotechnology company developing minimally invasive brain-computer interface (BCI) technology. The company's flagship product, the Stentrode device, received FDA clearance for human trials in 2021 and is being deployed through blood vessels to enable individuals with paralysis to control digital devices with their thoughts. Synchron is actively pursuing commercial applications in humanoid robotics teleoperation for mobility-impaired individuals.

Key Products